CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +35,790 | 156,042 | ||
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +74,226 | 230,268 | ||
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +202,260 | 432,528 | ||
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Shares withheld for taxes | −109,098 | $1.47 | $160K | 323,430 |
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −35,790 | 0 | ||
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −74,226 | 74,227 | ||
| 2026-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −202,260 | 404,520 | ||
| 2026-02-12 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +346,610 | 346,610 | ||
| 2026-02-12 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +519,920 | 519,920 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +27,917 | 75,543 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +35,790 | 111,333 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +74,227 | 185,560 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Shares withheld for taxes | −65,308 | $0.67 | $44K | 120,252 |
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −27,917 | 0 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −35,790 | 35,790 | ||
| 2025-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −74,227 | 148,453 | ||
| 2025-02-13 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +910,170 | 910,170 | ||
| 2025-02-13 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +606,780 | 606,780 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +27,916 | 43,101 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +35,790 | 78,891 |
Page 1 of 2 · 33 trades